Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese, Chinese Regulators Step Up Communications To Increase Effectiveness, Speed Up Approval - DIA China Conference

This article was originally published in PharmAsia News

Executive Summary

BEIJING - Communication with regulators is essential for clinical development success and increasingly drug companies are engaging with multiple regulators simultaneously along parallel tracks; regulators are responding in some surprising ways that show they are willing to change, leaders from China and Japan told scientists and executives at the China Drug Information Association meeting in Beijing May 18

You may also be interested in...



Approval Agency Reforms In Asia Leave Mark On Drug Pricing – DIA Asia New Drug Development Conference

Drug development doesn’t happen in a bubble. Speakers at DIA’s Asia New Drug Development Conference in Tokyo urged attendees to consider the impact of unique government pricing mechanisms in the region when bringing a new product to market.

China's Device Classification System And Country Of Origin Requirements Weigh On Foreign Companies

BEIJING - Foreign medical device manufacturers frustrated with China's medical device classification system and country of origin requirements are starting to take an "if you can't beat them, joint them" approach and are shifting more manufacturing to China, according to panelists at a recent regulatory conference in Beijing

China's Device Classification System And Country Of Origin Requirements Weigh On Foreign Companies

BEIJING - Foreign medical device manufacturers frustrated with China's medical device classification system and country of origin requirements are starting to take an "if you can't beat them, joint them" approach and are shifting more manufacturing to China, according to panelists at a recent regulatory conference in Beijing

Related Content

UsernamePublicRestriction

Register

LL1129367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel